These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Adherence to uptake of magnesium sulphate for neuroprotection in preterm births <30 weeks at Christchurch Hospital. Pang J N Z Med J; 2017 Jul; 130(1458):52-53. PubMed ID: 28694540 [No Abstract] [Full Text] [Related]
17. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials. Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471 [TBL] [Abstract][Full Text] [Related]
18. The effect of intravenous magnesium sulfate infusion on serum levels of sodium and potassium in patients with aneurysmal subarachnoid hemorrhage. Wong GK; Poon WS; Chan MT; Boet R; Gin T; Lam CW Magnes Res; 2007 Mar; 20(1):37-42. PubMed ID: 17536487 [TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effect of calcitonin gene-related peptide following subarachnoid hemorrhage. European CGRP in Subarachnoid Haemorrhage Study Group. Bell BA Ann N Y Acad Sci; 1995 Sep; 765():299-300. PubMed ID: 7486617 [No Abstract] [Full Text] [Related]
20. Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage. Taccone FS Crit Care Med; 2010 May; 38(5):1382-4. PubMed ID: 20404634 [No Abstract] [Full Text] [Related] [Next] [New Search]